High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 720-724

Spandidos Publications

Access to resources Recommend Favorite

Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas

By Högfeldt Therese   Johnsson Per   Grandér Dan   Bahnassy Abeer A.   Porwit Anna   Eid Salem   Österborg Anders   Zekri Abdel-Rahman N.   Lundahl Joachim   Khaled Mustafa Hussein   Mellstedt Håkan   Moshfegh Ali  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1158-1165

Informa Healthcare

Access to resources Recommend Favorite

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

By Hara Takeshi   Tsurumi Hisashi   Goto Naoe   Kanemura Nobuhiro   Yoshikawa Takeshi   Kasahara Senji   Yamada Toshiki   Sawada Michio   Goto Hideko   Fukuno Kenji   Kitagawa Jun-ichi   Yasuda Ichiro   Katsumura Naoki   Takemura Masao   Takahashi Takeshi   Takami Tsuyoshi   Moriwaki Hisataka  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1421-1428

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNA-204 targets signal transducer and activator of transcription 5 expression and inhibits proliferation of B-cell lymphoma cells

By                

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4567-4572

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

By Mitrović Zdravko  

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 243-247

Springer Publishing Company

Access to resources Recommend Favorite